- Pharmaceutical companies
- Europe
- Germany
- Regeneron Pharmaceuticals
Regeneron Pharmaceuticals in Germany
Web: https://www.regeneron.com/
Address:
-
Munich Office
Maximilianstrasse 35, Eingang A Munich, Bayern 80539 Germany
Phone: +49 89 24218000
Other Regeneron Pharmaceuticals's locations around the world
Clinical Trials sponsored by Regeneron Pharmaceuticals
-
Regeneron PharmaceuticalsHar inte rekryterat ännu
-
Regeneron PharmaceuticalsHar inte rekryterat ännu
-
Regeneron PharmaceuticalsRekryteringÅterfall/refraktärt follikulärt lymfom | Marginal zon lymfom (MZL)Korea, Republiken av, Australien, Spanien, Malaysia, Frankrike, Taiwan, Italien, Polen, Förenta staterna, Thailand, Storbritannien, Kalkon, Belgien, Tjeckien
-
Regeneron PharmaceuticalsRekrytering
-
Regeneron PharmaceuticalsRekryteringMedfödd hörselnedsättning sekundärt till bialleliska mutationer i Otoferlin-genen (OTOF) | Bialleliska mutationer i Gap Junction Beta 2 (GJB2) gen | Digeniska mutationer i GJB2/Gap Junction Beta 6 (GJB6) generFörenta staterna
-
Regeneron PharmaceuticalsHar inte rekryterat ännuDiabetiskt makulaödem (DME) | Neovaskulär åldersrelaterad makuladegeneration (nAMD)
-
Regeneron PharmaceuticalsRekryteringB-cells non-Hodgkins lymfom (B-NHL)Förenta staterna, Storbritannien
-
Regeneron PharmaceuticalsRekrytering
-
Regeneron PharmaceuticalsRekryteringIcke-alkoholisk Steatohepatit (NASH) | Metabolisk dysfunktion associerad Steatohepatit (MASH)Förenta staterna, Korea, Republiken av, Puerto Rico, Japan
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRekryteringIcke-småcellig lungcancerTyskland, Österrike, Frankrike
About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.